Evidence that Cereport's Ability to Increase Permeability of Rat Gliomas Is Dependent Upon Extent of Tumor Growth: Implications for Treating Newly Emerging Tumor Colonies
- 31 January 2000
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 161 (1), 234-244
- https://doi.org/10.1006/exnr.1999.7247
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Scatter factor/hepatocyte growth factor gene transfer increases rat blood–glioma barrier permeabilityBrain Research, 1999
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- Enhanced delivery of carboplatin into brain tumours with intravenous CereportTM (RMP-7): dramatic differences and insight gained from dosing parametersBritish Journal of Cancer, 1999
- Brain tumor development in rats is associated with changes in central nervous system cytokine and neuropeptide systemsBrain Research Bulletin, 1999
- Central analgesic actions of loperamide following transient permeation of the blood brain barrier with Cereport™ (RMP-7)Brain Research, 1998
- Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomasJournal of Neurosurgery, 1997
- Controlled Modulation of BBB Permeability Using the Bradykinin Agonist, RMP-7Experimental Neurology, 1996
- Unlocking the Blood–Brain Barrier: A Role for RMP-7 in Brain Tumor TherapyExperimental Neurology, 1996
- Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: Evidence for a sensitive, auto-regulated, receptor-mediated systemImmunopharmacology, 1996
- Controlling the vasculature: Angiogenesis, anti-angiogenesis and vascular targeting of gene therapyTrends in Pharmacological Sciences, 1995